Point72 Hong Kong LTD Danaher Corp Transaction History

Point72 Hong Kong LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$247.06 - $1507.4 $1.87 Million - $11.4 Million	-7,549 Reduced 31.51%	16,405 $4.24 Million
Q2 2022 Aug 15, 2022	BUY	$237.11 - $299.66 $5.56 Million - $7.03 Million	23,464 Added 4788.57%	23,954 $6.07 Million
Q3 2021 Nov 15, 2021	SELL	$272.21 - $332.43 $8.69 Million - $10.6 Million	-31,919 Reduced 98.49%	490 $149,000
Q4 2020 Feb 16, 2021	BUY	$212.5 - $245.46 $6.89 Million - $7.96 Million	32,409 New	32,409 $7.2 Million
Q2 2020 Aug 14, 2020	SELL	$128.7 - $176.83 $709,008 - $974,156	-5,509 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$121.39 - $169.05 $668,737 - $931,296	5,509 New	5,509 $763,000
Q4 2018 Feb 14, 2019	SELL	$94.85 - $109.54 $1,897 - $2,190	-20 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$98.13 - $108.9 $1,962 - $2,178	20 New	20 $2,000
Q1 2018 May 15, 2018	SELL	$92.16 - $103.8 $4,423 - $4,982	-48 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$85.26 - $94.62 $27,965 - $31,035	-328 Reduced 87.23%	48 $4,000
Q3 2017 Nov 14, 2017	BUY	$79.29 - $88.45 $29,813 - $33,257	376	376 $32,000

2,511

539M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $168B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.